CVE:ICO

iCo Therapeutics Competitors

C$0.10

0.00 (0.00 %)

(As of 03/19/2021)

Add

Compare

Today's Range

C$0.10

Now: C$0.11▼

C$0.11

50-Day Range

C$0.08

MA: C$0.10▼

C$0.13

52-Week Range

C$0.03

Now: C$0.11▼

C$0.16

Volume1.31 million shs

Average Volume3.16 million shs

Market CapitalizationC$18.27 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

iCo Therapeutics (CVE:ICO) Vs. QPT, CZO, CTX, KNE, GSD, and PAS

Should you be buying ICO stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to iCo Therapeutics, including Quest PharmaTech (QPT), Ceapro (CZO), Crescita Therapeutics (CTX), Kane Biotech (KNE), Devonian Health Group (GSD), and Pascal Biosciences (PAS).

iCo Therapeutics vs. Quest PharmaTech Stock

Quest PharmaTech (CVE:QPT) and iCo Therapeutics (CVE:ICO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for Quest PharmaTech and iCo Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest PharmaTech	0	0	0	0	N/A
iCo Therapeutics	0	0	0	0	N/A

Valuation & Earnings

This table compares Quest PharmaTech and iCo Therapeutics' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest PharmaTech	C$38,871.00	474.71	C$109.88 million	C$0.66	0.17
iCo Therapeutics	N/A	N/A	N/A	C($0.01)	-8.75

Quest PharmaTech has higher revenue and earnings than iCo Therapeutics. iCo Therapeutics is trading at a lower price-to-earnings ratio than Quest PharmaTech, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Quest PharmaTech and iCo Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Quest PharmaTech	N/A	N/A	N/A
iCo Therapeutics	N/A	N/A	N/A

Summary

Quest PharmaTech beats iCo Therapeutics on 3 of the 3 factors compared between the two stocks.

iCo Therapeutics vs. Ceapro Stock

Ceapro (CVE:CZO) and iCo Therapeutics (CVE:ICO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk.

Valuation & Earnings

This table compares Ceapro and iCo Therapeutics' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ceapro	C$16.14 million	3.46	C$2.56 million	C$0.03	21.82
iCo Therapeutics	N/A	N/A	N/A	C($0.01)	-8.75

Ceapro has higher revenue and earnings than iCo Therapeutics. iCo Therapeutics is trading at a lower price-to-earnings ratio than Ceapro, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and price targets for Ceapro and iCo Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ceapro	0	0	0	0	N/A
iCo Therapeutics	0	0	0	0	N/A

Profitability

This table compares Ceapro and iCo Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ceapro	N/A	N/A	N/A
iCo Therapeutics	N/A	N/A	N/A

Summary

Ceapro beats iCo Therapeutics on 3 of the 3 factors compared between the two stocks.

iCo Therapeutics vs. Crescita Therapeutics Stock

Crescita Therapeutics (TSE:CTX) and iCo Therapeutics (CVE:ICO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and profitability.

Profitability

This table compares Crescita Therapeutics and iCo Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Crescita Therapeutics	N/A	N/A	N/A
iCo Therapeutics	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and price targets for Crescita Therapeutics and iCo Therapeutics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescita Therapeutics	0	0	0	0	N/A
iCo Therapeutics	0	0	0	0	N/A

Earnings and Valuation

This table compares Crescita Therapeutics and iCo Therapeutics' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescita Therapeutics	C$15.64 million	1.14	C$41,296.00	C$0.00	430.00
iCo Therapeutics	N/A	N/A	N/A	C($0.01)	-8.75

Crescita Therapeutics has higher revenue and earnings than iCo Therapeutics. iCo Therapeutics is trading at a lower price-to-earnings ratio than Crescita Therapeutics, indicating that it is currently the more affordable of the two stocks.

Summary

Crescita Therapeutics beats iCo Therapeutics on 3 of the 3 factors compared between the two stocks.

iCo Therapeutics vs. Kane Biotech Stock

iCo Therapeutics (CVE:ICO) and Kane Biotech (CVE:KNE) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Profitability

This table compares iCo Therapeutics and Kane Biotech's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
iCo Therapeutics	N/A	N/A	N/A
Kane Biotech	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for iCo Therapeutics and Kane Biotech, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iCo Therapeutics	0	0	0	0	N/A
Kane Biotech	0	0	0	0	N/A

Valuation & Earnings

This table compares iCo Therapeutics and Kane Biotech's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iCo Therapeutics	N/A	N/A	N/A	C($0.01)	-8.75
Kane Biotech	C$1.34 million	13.76	C$-3,801,490.00	C($0.04)	-4.86

iCo Therapeutics has higher earnings, but lower revenue than Kane Biotech. iCo Therapeutics is trading at a lower price-to-earnings ratio than Kane Biotech, indicating that it is currently the more affordable of the two stocks.

Summary

Kane Biotech beats iCo Therapeutics on 2 of the 3 factors compared between the two stocks.

iCo Therapeutics vs. Devonian Health Group Stock

iCo Therapeutics (CVE:ICO) and Devonian Health Group (CVE:GSD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Profitability

This table compares iCo Therapeutics and Devonian Health Group's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
iCo Therapeutics	N/A	N/A	N/A
Devonian Health Group	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for iCo Therapeutics and Devonian Health Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iCo Therapeutics	0	0	0	0	N/A
Devonian Health Group	0	0	0	0	N/A

Valuation & Earnings

This table compares iCo Therapeutics and Devonian Health Group's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iCo Therapeutics	N/A	N/A	N/A	C($0.01)	-8.75
Devonian Health Group	C$1.59 million	15.78	C$-4,457,184.00	C($0.05)	-5.63

iCo Therapeutics has higher earnings, but lower revenue than Devonian Health Group. iCo Therapeutics is trading at a lower price-to-earnings ratio than Devonian Health Group, indicating that it is currently the more affordable of the two stocks.

Summary

Devonian Health Group beats iCo Therapeutics on 2 of the 3 factors compared between the two stocks.

iCo Therapeutics vs. Pascal Biosciences Stock

iCo Therapeutics (CVE:ICO) and Pascal Biosciences (CVE:PAS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Profitability

This table compares iCo Therapeutics and Pascal Biosciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
iCo Therapeutics	N/A	N/A	N/A
Pascal Biosciences	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for iCo Therapeutics and Pascal Biosciences, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iCo Therapeutics	0	0	0	0	N/A
Pascal Biosciences	0	0	0	0	N/A

Valuation & Earnings

This table compares iCo Therapeutics and Pascal Biosciences' top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iCo Therapeutics	N/A	N/A	N/A	C($0.01)	-8.75
Pascal Biosciences	N/A	N/A	N/A	C($0.02)	-4.09

iCo Therapeutics is trading at a lower price-to-earnings ratio than Pascal Biosciences, indicating that it is currently the more affordable of the two stocks.